• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与单胺转运体相互作用的蛋白质:现状与未来挑战。

Proteins interacting with monoamine transporters: current state and future challenges.

机构信息

Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States.

出版信息

Biochemistry. 2011 Aug 30;50(34):7295-310. doi: 10.1021/bi200405c. Epub 2011 Aug 5.

DOI:10.1021/bi200405c
PMID:21797260
Abstract

Plasma membrane and vesicular transporters for the biogenic amines, dopamine, norepinephrine, and serotonin, represent a group of proteins that play a crucial role in the regulation of neurotransmission. Clinically, mono amine transporters are the primary targets for the actions of many therapeutic agents used to treat mood disorders, as well as the site of action for highly addictive psychostimulants such as cocaine, amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine. Over the past decade, the use of approaches such as yeast two-hybrid and proteomics has identified a multitude of transporter interacting proteins, suggesting that the function and regulation of these transporters are more complex than previously anticipated. With the increasing number of interacting proteins, the rules dictating transporter synthesis, assembly, targeting, trafficking, and function are beginning to be deciphered. Although many of these protein interactions have yet to be fully characterized, current knowledge is beginning to shed light on novel transporter mechanisms involved in monoamine homeostasis, the molecular actions of psychostimulants, and potential disease mechanisms. While future studies resolving the spatial and temporal resolution of these, and yet unknown, interactions will be needed, the realization that monoamine transporters do not work alone opens the path to a plethora of possible pharmacological interventions.

摘要

血浆膜和囊泡转运体对于生物胺,如多巴胺、去甲肾上腺素和 5-羟色胺,是一组在神经递质调节中起着关键作用的蛋白质。临床上,单胺转运体是许多用于治疗情绪障碍的治疗药物的主要作用靶点,也是高度成瘾性精神兴奋剂如可卡因、安非他命、甲基苯丙胺和 3,4-亚甲二氧基甲基苯丙胺的作用部位。在过去的十年中,使用酵母双杂交和蛋白质组学等方法已经鉴定出许多转运体相互作用蛋白,这表明这些转运体的功能和调节比以前预期的更为复杂。随着相互作用蛋白数量的增加,决定转运体合成、组装、靶向、运输和功能的规则开始被破译。尽管这些蛋白相互作用中的许多仍未被充分表征,但目前的知识开始揭示涉及单胺稳态、精神兴奋剂的分子作用以及潜在疾病机制的新型转运体机制。虽然需要进一步的研究来解析这些以及尚未确定的相互作用的时空分辨率,但认识到单胺转运体并非单独起作用,为大量可能的药理学干预开辟了道路。

相似文献

1
Proteins interacting with monoamine transporters: current state and future challenges.与单胺转运体相互作用的蛋白质:现状与未来挑战。
Biochemistry. 2011 Aug 30;50(34):7295-310. doi: 10.1021/bi200405c. Epub 2011 Aug 5.
2
Regulation of monoamine transporters: Role of transporter phosphorylation.单胺转运体的调节:转运体磷酸化的作用。
Pharmacol Ther. 2011 Feb;129(2):220-38. doi: 10.1016/j.pharmthera.2010.09.009. Epub 2010 Oct 15.
3
Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.单胺转运体的调节:精神兴奋剂和治疗性抗抑郁药的影响
AAPS J. 2005 Oct 27;7(3):E728-38. doi: 10.1208/aapsj070373.
4
The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.麦角酸二乙酰胺在人体单胺转运体上的表现不同于 3,4-亚甲基二氧甲基苯丙胺,主要是因为它对囊泡单胺转运体的效力较低。
Eur J Pharmacol. 2015 May 15;755:119-26. doi: 10.1016/j.ejphar.2015.03.004. Epub 2015 Mar 11.
5
Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.对质膜和囊泡单胺转运体具有增强亲和力和选择性的洛贝林类似物。
J Pharmacol Exp Ther. 2004 Sep;310(3):1035-45. doi: 10.1124/jpet.104.068098. Epub 2004 Apr 30.
6
A kinome wide screen identifies novel kinases involved in regulation of monoamine transporter function.全激酶组筛选鉴定出参与单胺转运体功能调控的新型激酶。
Neurochem Int. 2016 Sep;98:103-14. doi: 10.1016/j.neuint.2016.03.013. Epub 2016 Mar 26.
7
Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.脂质微区对单胺转运体和受体的调节:与抑郁症的关系。
Neuropsychopharmacology. 2018 Oct;43(11):2165-2179. doi: 10.1038/s41386-018-0133-6. Epub 2018 Jun 28.
8
Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.囊泡单胺转运体2基因敲除导致新生儿死亡以及对可卡因和苯丙胺超敏。
Neuron. 1997 Dec;19(6):1285-96. doi: 10.1016/s0896-6273(00)80419-5.
9
2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α-adrenergic receptors.2-氨基茚满及其环取代衍生物与质膜单胺转运体和α-肾上腺素能受体相互作用。
Psychopharmacology (Berl). 2019 Mar;236(3):989-999. doi: 10.1007/s00213-019-05207-1. Epub 2019 Mar 23.
10
Impact of psychostimulants on vesicular monoamine transporter function.精神兴奋剂对囊泡单胺转运体功能的影响。
Eur J Pharmacol. 2003 Oct 31;479(1-3):283-9. doi: 10.1016/j.ejphar.2003.08.077.

引用本文的文献

1
Decoding serotonin: the molecular symphony behind depression.解码血清素:抑郁症背后的分子交响曲。
Front Cell Neurosci. 2025 Apr 24;19:1572462. doi: 10.3389/fncel.2025.1572462. eCollection 2025.
2
Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants.天然血清素转运体与精神兴奋剂复合物的结构和膜相互作用。
Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2304602120. doi: 10.1073/pnas.2304602120. Epub 2023 Jul 12.
3
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment.
二肽基肽酶 4(DPP4)抑制剂在持续接受血管紧张素转换酶(ACE)抑制剂治疗期间增加儿茶酚胺而不增加血压。
Hypertension. 2022 Apr;79(4):827-835. doi: 10.1161/HYPERTENSIONAHA.121.18348. Epub 2022 Jan 20.
4
Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.通过接近标记鉴定多巴胺转运体的新型脂质和蛋白质潜在伴侣。
Cell Mol Life Sci. 2021 Dec;78(23):7733-7756. doi: 10.1007/s00018-021-03998-1. Epub 2021 Oct 28.
5
Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux.鉴定参与G蛋白βγ诱导多巴胺流出的多巴胺转运体羧基末端的关键残基。
Front Pharmacol. 2021 Mar 24;12:642881. doi: 10.3389/fphar.2021.642881. eCollection 2021.
6
Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.多巴胺 D2 自身受体相互作用组:以受体复合物为靶点治疗物质使用障碍的策略。
Pharmacol Ther. 2020 Sep;213:107583. doi: 10.1016/j.pharmthera.2020.107583. Epub 2020 May 27.
7
Gβγ subunit activation promotes dopamine efflux through the dopamine transporter.Gβγ 亚基的激活通过多巴胺转运体促进多巴胺的外排。
Mol Psychiatry. 2017 Dec;22(12):1673-1679. doi: 10.1038/mp.2017.176. Epub 2017 Sep 12.
8
Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.5-HT1B 受体激动剂作为精神兴奋剂使用障碍治疗药物的临床前证据。
Int J Neuropsychopharmacol. 2017 Aug 1;20(8):644-653. doi: 10.1093/ijnp/pyx025.
9
Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity.大鼠黑质中D2受体的急性耗竭改变背侧纹状体中的多巴胺动力学及药物反应性。
Front Behav Neurosci. 2017 Jan 19;10:248. doi: 10.3389/fnbeh.2016.00248. eCollection 2016.
10
Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.秀丽隐杆线虫多巴胺转运体决定体内轴突输出和突触定位的序列决定因素。
Mol Cell Neurosci. 2017 Jan;78:41-51. doi: 10.1016/j.mcn.2016.11.011. Epub 2016 Nov 30.